30s Ad: $34 - $42
60s Ad: $40 - $48
CPM Category: Health & Fitness
Different podcast categories command different CPM (cost per mille) rates based on advertiser demand and audience value.
Socials metrics & links
Socials metrics & links
No data
No data
Podcast LinksLinks to the podcast's website, socials, and more
We're dispensing stories of success from across the continuum of care.
Talk to Your Pharmacist is a podcast for pharmacists, student pharmacists, and others across the country to hear from industry leaders about their leadership stories and current healthcare topics. The Talk to Your Pharmacist podcast was founded and hosted by pharmacist, Dr. Hillary Blackburn.
We're dispensing stories of success from across the continuum of care.
Talk to Your Pharmacist is a podcast for pharmacists, student pharmacists, and others across the country to hear from industry leaders about their leadership stories and current healthcare topics. The Talk to Your Pharmacist podcast was founded and hosted by pharmacist, Dr. Hillary Blackburn.
Producers, Hosts, and Production Team
Searching
Searching for producer information... This may take a moment.
Producers, Hosts, and Production Team
No producer information available yet. Click "Find producers" to search for the production team.
Emails, Phones, and Addresses
Contact Page Emails
Emails listed specifically on the website's official contact page.
No contact pages found.
General Website Emails
Emails found on general website pages (e.g., about, info), not the main contact page.
No website emails found.
Externally Sourced Emails
Emails discovered using automated web scraping across the internet.
No external emails found.
RSS Emails
Email addresses extracted directly from the website's or podcast's RSS feed(s).
Here's a quick summary of the last 4 episodes on Talk to Your Pharmacist.
Hosts
Hillary Blackburn
Dr. Hillary Blackburn
Previous Guests
Lewis Bender
Lewis Bender is the Chairman and CEO of Intensity Therapeutics, a late-stage clinical biotechnology company focused on developing innovative cancer treatments. Under his leadership, the company aims to help patients live longer, higher quality lives by discovering, developing, and commercializing first-in-class cancer drugs that minimize side effects while training the immune system to combat cancer. Bender has been instrumental in advancing the company's lead product candidate, INT230-6, which is currently undergoing human clinical studies to treat refractory solid tumors. His expertise in the field of biotechnology and commitment to improving patient outcomes have positioned him as a key figure in the fight against cancer.
Lewis Bender is the Chairman and CEO of Intensity Therapeutics, a late-stage clinical biotechnology company focused on developing innovative cancer treatments. Under his leadership, the company aims to help patients live longer, higher quality lives by discovering, developing, and commercializing first-in-class cancer drugs that minimize side effects while training the immune system to combat cancer. Bender has been instrumental in advancing the company's lead product candidate, INT230-6, which is currently undergoing human clinical studies to treat refractory solid tumors. His expertise in the field of biotechnology and commitment to improving patient outcomes have positioned him as a key figure in the fight against cancer.
Tom Campbell
Tom Campbell is the Dean and Associate Professor of Pharmacy Practice at Lipscomb University College of Pharmacy in Nashville. He received his Pharm.D. degree from the University of Tennessee College of Pharmacy and has been board certified in pharmacotherapy since 1995. His prior work experience includes a pharmacy practice residency with the VA Medical Center in Memphis, and positions at Columbus Regional Health System in Columbus, Georgia, and Sanofi Pharmaceuticals. He has also served as a Clinical Assistant Professor at Auburn University. Tom has held leadership roles, including President of the Tennessee Pharmacists Association and has been a member of several professional organizations such as AACP, ASHP, APhA, CPFI, and TPA. He is the recipient of the 2024 APhA Academy of Student Pharmacists Outstanding Dean Award, recognizing his significant contributions to student pharmacists and community service. Additionally, he is a Sunday school teacher and former elder at the Spring Meadows Church of Christ in Spring Hill, TN, and has participated in medical mission campaigns in Central America. Tom Campbell is a dedicated leader who views his work as a calling to serve others.
Tom Campbell is the Dean and Associate Professor of Pharmacy Practice at Lipscomb University College of Pharmacy in Nashville. He received his Pharm.D. degree from the University of Tennessee College of Pharmacy and has been board certified in pharmacotherapy since 1995. His prior work experience includes a pharmacy practice residency with the VA Medical Center in Memphis, and positions at Columbus Regional Health System in Columbus, Georgia, and Sanofi Pharmaceuticals. He has also served as a Clinical Assistant Professor at Auburn University. Tom has held leadership roles, including President of the Tennessee Pharmacists Association and has been a member of several professional organizations such as AACP, ASHP, APhA, CPFI, and TPA. He is the recipient of the 2024 APhA Academy of Student Pharmacists Outstanding Dean Award, recognizing his significant contributions to student pharmacists and community service. Additionally, he is a Sunday school teacher and former elder at the Spring Meadows Church of Christ in Spring Hill, TN, and has participated in medical mission campaigns in Central America. Tom Campbell is a dedicated leader who views his work as a calling to serve others.
Arielle Miliambro
Arielle Miliambro is a Partner specializing in regulatory and transactional law within the Healthcare & Life Sciences departments. She assists clients with legal issues related to telehealth, data privacy, value-based care, and fraud compliance. Arielle offers counsel on regulations like the Anti-Kickback Statute and prepares requests for OIG Advisory Opinions. She guides stakeholders in telehealth and digital health models on fraud, corporate practice, and virtual care requirements. Additionally, she advises clients on data security and privacy issues, including HIPAA compliance and data breach response. Her expertise extends to pharmacy clients, whom she advises on remote prescription processing, compliance, and licensing board matters. Arielle also assists practitioners with in-office dispensing and scope of practice concerns, and supports clients with corporate transactional matters, drafting various legal agreements and documents.
Arielle Miliambro is a Partner specializing in regulatory and transactional law within the Healthcare & Life Sciences departments. She assists clients with legal issues related to telehealth, data privacy, value-based care, and fraud compliance. Arielle offers counsel on regulations like the Anti-Kickback Statute and prepares requests for OIG Advisory Opinions. She guides stakeholders in telehealth and digital health models on fraud, corporate practice, and virtual care requirements. Additionally, she advises clients on data security and privacy issues, including HIPAA compliance and data breach response. Her expertise extends to pharmacy clients, whom she advises on remote prescription processing, compliance, and licensing board matters. Arielle also assists practitioners with in-office dispensing and scope of practice concerns, and supports clients with corporate transactional matters, drafting various legal agreements and documents.
Marc Ryan
Marc Ryan has extensive leadership experience across the healthcare industry. He was a founding executive and President of MedHOK, which was acquired by Hearst Health. Marc has launched and operated multiple health plans and served in senior policy roles in state and federal government, including as state management secretary of Connecticut. He played a significant role in building Medicare Part D's relationship with state drug assistance programs in 2006 and created Connecticut's Medicaid and children's health managed care programs, as well as its long-term care continuum. Marc is also the author of 'The Healthcare Labyrinth: A Guide To Navigating Health Plans and Fixing American Health Insurance' and hosts the Healthcare Labyrinth Podcast.
Marc Ryan has extensive leadership experience across the healthcare industry. He was a founding executive and President of MedHOK, which was acquired by Hearst Health. Marc has launched and operated multiple health plans and served in senior policy roles in state and federal government, including as state management secretary of Connecticut. He played a significant role in building Medicare Part D's relationship with state drug assistance programs in 2006 and created Connecticut's Medicaid and children's health managed care programs, as well as its long-term care continuum. Marc is also the author of 'The Healthcare Labyrinth: A Guide To Navigating Health Plans and Fixing American Health Insurance' and hosts the Healthcare Labyrinth Podcast.
Topics Discussed
cancer drugs
biotechnology
clinical trials
triple-negative breast cancer
immune system
Intensity Therapeutics
INT230-6
SAKK
faith
work
healthcare
pharmacy
leadership
job satisfaction
professional fulfillment
telehealth
telepharmacy
data privacy
value-based care
fraud compliance
HIPAA compliance
remote prescription processing
pharmacy compliance
DEA prescribing
pharmacist obligations
health plans
American health insurance
drug spending
Medicare
Medicaid
GLP-1s
drug prices
Medicare drug price negotiations
PBM reform
medication adherence
YouTube Channel
Podcast has no YouTube channel.
Instagram Profile
Podcast has no Instagram profile.
Episodes
Here's the recent few episodes on Talk to Your Pharmacist.
0:0034:53
Bringing New Cancer Drugs to Market with Founder & CEO, Lewis Bender
Hosts
Hosts of this podcast episode
Hillary Blackburn
Guests
Guests of this podcast episode
Lewis Bender
Keywords
Keywords of this podcast episode
cancer drugsbiotechnologyclinical trialstriple-negative breast cancerimmune systemIntensity TherapeuticsINT230-6SAKK
In this episode, our guest is Lewis Bender, Chairman, and CEO, of Intensity Therapeutics’ Founder which is a late-stage clinical biotechnology company whose mission is to help patients live longer, higher quality lives by discovering, developing, and commercializing first-in-class cancer drugs that attenuate tumors with minimal side effects, while training the patient’s immune system to fight the cancer. The Company’s lead product candidate, INT230-6, is currently in human clinical studies to treat refractory solid tumors.
Talking points: Milestone Achievement: "Congratulations on dosing the first patient in the INVINCIBLE-4 Phase 2 clinical trial for triple-negative breast cancer. Can you walk us through the significance of this milestone and what it means for the future of Intensity Therapeutics?"
Innovative Approach of INT230-6: "Intensity Therapeutics focuses on developing cancer treatments that not only attenuate tumors with minimal side effects but also train the immune system to fight cancer. Could you explain how your lead product, INT230-6, achieves this unique approach and what differentiates it from existing cancer therapies?"
Collaboration with SAKK: "Your partnership with The Swiss Group for Clinical Cancer Research (SAKK) is a key component of the INVINCIBLE-4 study. How does this collaboration enhance your clinical development efforts, and what are you hoping to achieve together in this trial?"
Impact on Triple-Negative Breast Cancer (TNBC): "Triple-negative breast cancer is known for being particularly aggressive and having limited treatment options. How does INT230-6 address the unmet needs of TNBC patients, and what potential impact do you foresee it having on improving patient outcomes?"
Future Vision and Next Steps: "Looking ahead, what are the next steps for Intensity Therapeutics following the initiation of the INVINCIBLE-4 study? How do you envision the future of your company in the evolving landscape of cancer therapeutics?"
In this episode, our guest is Lewis Bender, Chairman, and CEO, of Intensity Therapeutics’ Founder which is a late-stage clinical biotechnology company whose mission is to help patients live longer, higher quality lives by discovering, developing, and commercializing first-in-class cancer drugs that attenuate tumors with minimal side effects, while training the patient’s immune system to fight the cancer. The Company’s lead product candidate, INT230-6, is currently in human clinical studies to treat refractory solid tumors.
Talking points: Milestone Achievement: "Congratulations on dosing the first patient in the INVINCIBLE-4 Phase 2 clinical trial for triple-negative breast cancer. Can you walk us through the significance of this milestone and what it means for the future of Intensity Therapeutics?"
Innovative Approach of INT230-6: "Intensity Therapeutics focuses on developing cancer treatments that not only attenuate tumors with minimal side effects but also train the immune system to fight cancer. Could you explain how your lead product, INT230-6, achieves this unique approach and what differentiates it from existing cancer therapies?"
Collaboration with SAKK: "Your partnership with The Swiss Group for Clinical Cancer Research (SAKK) is a key component of the INVINCIBLE-4 study. How does this collaboration enhance your clinical development efforts, and what are you hoping to achieve together in this trial?"
Impact on Triple-Negative Breast Cancer (TNBC): "Triple-negative breast cancer is known for being particularly aggressive and having limited treatment options. How does INT230-6 address the unmet needs of TNBC patients, and what potential impact do you foresee it having on improving patient outcomes?"
Future Vision and Next Steps: "Looking ahead, what are the next steps for Intensity Therapeutics following the initiation of the INVINCIBLE-4 study? How do you envision the future of your company in the evolving landscape of cancer therapeutics?"
In this episode, our guest is Tom Campbell, the Dean and Associate Professor of Pharmacy Practice at Lipscomb University College of Pharmacy in Nashville. Dr. Campbell received his Pharm.D. degree from the University of Tennessee College of Pharmacy and received board certification in pharmacotherapy in 1995. His prior work experience includes a pharmacy practice residency with VA Medical Center in Memphis, Columbus Regional Health System in Columbus, Georgia, and Sanofi Pharmaceuticals. He also served as Clinical Assistant Professor at Auburn University. Dr. Campbell has served as President of the Tennessee Pharmacists Association and served on the Board of Directors. He is a member of AACP, ASHP, APhA, CPFI and TPA. He's a recipient of the 2024 APhA Academy of Student Pharmacists Outstanding Dean Award which was established to recognize a school or college of pharmacy dean who has made significant contributions to the APhA-ASP Chapter and promoted with distinction the welfare of student pharmacists through various community service, leadership and professional activities.
Dr. Campbell is a Sunday school teacher and former elder at the Spring Meadows Church of Christ in Spring Hill, TN. He has traveled to Central America as part of medical mission campaigns numerous times. Dr. Campbell and his late wife, Susan, have three sons.
During the discussion, we explored questions around:
How faith influences our daily work in healthcare
The ways faith impacts health behaviors and decision-making
The role faith plays in job satisfaction and professional fulfillment
It was inspiring to engage in meaningful dialogue with a leader who also sees their work as a calling to serve others. I'm grateful to Dean Campbell at Lipscomb University for fostering conversations that remind us of the deeper purpose behind our careers.
In this episode, our guest is Tom Campbell, the Dean and Associate Professor of Pharmacy Practice at Lipscomb University College of Pharmacy in Nashville. Dr. Campbell received his Pharm.D. degree from the University of Tennessee College of Pharmacy and received board certification in pharmacotherapy in 1995. His prior work experience includes a pharmacy practice residency with VA Medical Center in Memphis, Columbus Regional Health System in Columbus, Georgia, and Sanofi Pharmaceuticals. He also served as Clinical Assistant Professor at Auburn University. Dr. Campbell has served as President of the Tennessee Pharmacists Association and served on the Board of Directors. He is a member of AACP, ASHP, APhA, CPFI and TPA. He's a recipient of the 2024 APhA Academy of Student Pharmacists Outstanding Dean Award which was established to recognize a school or college of pharmacy dean who has made significant contributions to the APhA-ASP Chapter and promoted with distinction the welfare of student pharmacists through various community service, leadership and professional activities.
Dr. Campbell is a Sunday school teacher and former elder at the Spring Meadows Church of Christ in Spring Hill, TN. He has traveled to Central America as part of medical mission campaigns numerous times. Dr. Campbell and his late wife, Susan, have three sons.
During the discussion, we explored questions around:
How faith influences our daily work in healthcare
The ways faith impacts health behaviors and decision-making
The role faith plays in job satisfaction and professional fulfillment
It was inspiring to engage in meaningful dialogue with a leader who also sees their work as a calling to serve others. I'm grateful to Dean Campbell at Lipscomb University for fostering conversations that remind us of the deeper purpose behind our careers.
In this episode, our guest is Arielle Miliambro, a Partner specializing in regulatory and transactional law within the Healthcare & Life Sciences departments. She assists clients with legal issues related to telehealth, data privacy, value-based care, and fraud compliance. She offers counsel on regulations like the Anti-Kickback Statute and prepares requests for OIG Advisory Opinions.
Arielle also guides stakeholders in telehealth and digital health models on fraud, corporate practice, and virtual care requirements. Additionally, she advises clients on data security and privacy issues, including HIPAA compliance and data breach response. She works with providers to develop value-based care and alternative payment models.
Her expertise extends to pharmacy clients, whom she advises on remote prescription processing, compliance, and licensing board matters. She also assists practitioners with in-office dispensing and scope of practice concerns. Furthermore, Arielle supports clients with corporate transactional matters, drafting various legal agreements and documents.
Telehealth Topics for Podcast
What is the difference between telehealth and telepharmacy
Pharmacy role in bigger picture of telehealth models
Considerations for kickbacks/fee splitting in telehealth models depending on pharmacy’s reimbursement
Pharmacists duty to validate script prior to dispensing
Telehealth “red flags”
Where does the line get drawn as to pharmacist’s obligations with respect to the actual patient encounter between prescriber/patient
Covid changes
State
Licensing flexibility for prescribers
Scope of practice of pharmacists
Federal
Telehealth reimbursement
DEA prescribing
History / status of new rules related to CDS prescribing
Telehealth vs Telepharmacy Differences
Brief overview distinguishing the definitions of each:
In this episode, our guest is Arielle Miliambro, a Partner specializing in regulatory and transactional law within the Healthcare & Life Sciences departments. She assists clients with legal issues related to telehealth, data privacy, value-based care, and fraud compliance. She offers counsel on regulations like the Anti-Kickback Statute and prepares requests for OIG Advisory Opinions.
Arielle also guides stakeholders in telehealth and digital health models on fraud, corporate practice, and virtual care requirements. Additionally, she advises clients on data security and privacy issues, including HIPAA compliance and data breach response. She works with providers to develop value-based care and alternative payment models.
Her expertise extends to pharmacy clients, whom she advises on remote prescription processing, compliance, and licensing board matters. She also assists practitioners with in-office dispensing and scope of practice concerns. Furthermore, Arielle supports clients with corporate transactional matters, drafting various legal agreements and documents.
Telehealth Topics for Podcast
What is the difference between telehealth and telepharmacy
Pharmacy role in bigger picture of telehealth models
Considerations for kickbacks/fee splitting in telehealth models depending on pharmacy’s reimbursement
Pharmacists duty to validate script prior to dispensing
Telehealth “red flags”
Where does the line get drawn as to pharmacist’s obligations with respect to the actual patient encounter between prescriber/patient
Covid changes
State
Licensing flexibility for prescribers
Scope of practice of pharmacists
Federal
Telehealth reimbursement
DEA prescribing
History / status of new rules related to CDS prescribing
Telehealth vs Telepharmacy Differences
Brief overview distinguishing the definitions of each:
A Guide To Navigating Health Plans and Fixing American Health Insurance with Mark Ryan
Hosts
Hosts of this podcast episode
Hillary Blackburn
Guests
Guests of this podcast episode
Marc Ryan
Keywords
Keywords of this podcast episode
health plansAmerican health insurancedrug spendingMedicareMedicaidGLP-1sdrug pricesMedicare drug price negotiationsPBM reformmedication adherence
In this episode, Our guest is MARC RYAN, who has extensive leadership experience across the healthcare industry. Most recently, he was a founding executive and President of MedHOK (MHK, acquired by Hearst Health). He has launched and operated multiple health plans. Marc served in senior policy roles in state and federal government, including as state management secretary of Connecticut and helping build Medicare Part D’s relationship with state drug assistance programs in 2006. He created Connecticut’s Medicaid and children’s health managed care programs and its long-term care continuum. Marc is the author of The Healthcare Labyrinth: A Guide To Navigating Health Plans and Fixing American Health Insurance and the host of the Healthcare Labyrinth Podcast.
Topics covered: (1) What are the trends in drug spending and the impact on all types of insurance products -- Medicare, Medicaid, commercial/employer -- cost trends for medical and retail
(2) What is driving the major increases in drug costs/spending?
(3) How are GLP-1s treated across various products? And will coverage change?
(4) American drug prices compared with others? Can you discuss how we compare vs. other developed countries and why (more than twice -- in many cases 3, 4, and 5 times more -- impacts on employer, Medicare, etc. -- rising percentage of healthcare as well as employer)
(5) Medicare drug price negotiations -- what it is and what has happened so far? where do you stand? (6) A lot is occurring in plans on PA, formularies, benefit design, PBM reform -- a very hot topic -can you tell us more about this and what you predict? (7) Can you explain the traditional PBMs vs. transparent ones? FTC lawsuit against PBMs and drug supply channel issues
(8) There have been major changes to Part D and it is impacting Medicare Advantage and Part D -- what is happening for 2025 benefits as well as can you tell us a little on a study that questioned the value of Part D?
(9a) Medication Adherence in the Star program for MA and Part D plans -- key. Can you tell us more here? 9(b) How could pharmacists in the community support medication adherence etc -- Will discuss trends from health plans about recognizing the best way to ensure medication reconciliation and adherence is teaming up with pharmacists.
In this episode, Our guest is MARC RYAN, who has extensive leadership experience across the healthcare industry. Most recently, he was a founding executive and President of MedHOK (MHK, acquired by Hearst Health). He has launched and operated multiple health plans. Marc served in senior policy roles in state and federal government, including as state management secretary of Connecticut and helping build Medicare Part D’s relationship with state drug assistance programs in 2006. He created Connecticut’s Medicaid and children’s health managed care programs and its long-term care continuum. Marc is the author of The Healthcare Labyrinth: A Guide To Navigating Health Plans and Fixing American Health Insurance and the host of the Healthcare Labyrinth Podcast.
Topics covered: (1) What are the trends in drug spending and the impact on all types of insurance products -- Medicare, Medicaid, commercial/employer -- cost trends for medical and retail
(2) What is driving the major increases in drug costs/spending?
(3) How are GLP-1s treated across various products? And will coverage change?
(4) American drug prices compared with others? Can you discuss how we compare vs. other developed countries and why (more than twice -- in many cases 3, 4, and 5 times more -- impacts on employer, Medicare, etc. -- rising percentage of healthcare as well as employer)
(5) Medicare drug price negotiations -- what it is and what has happened so far? where do you stand? (6) A lot is occurring in plans on PA, formularies, benefit design, PBM reform -- a very hot topic -can you tell us more about this and what you predict? (7) Can you explain the traditional PBMs vs. transparent ones? FTC lawsuit against PBMs and drug supply channel issues
(8) There have been major changes to Part D and it is impacting Medicare Advantage and Part D -- what is happening for 2025 benefits as well as can you tell us a little on a study that questioned the value of Part D?
(9a) Medication Adherence in the Star program for MA and Part D plans -- key. Can you tell us more here? 9(b) How could pharmacists in the community support medication adherence etc -- Will discuss trends from health plans about recognizing the best way to ensure medication reconciliation and adherence is teaming up with pharmacists.
